Pelthos Therapeutics PTHS
NYSE PTHS
$20.66 -0.35 (-1.67%)
As of: Oct 1, 2026 · 3:53 PM EDT

Pelthos Therapeutics (PTHS) Other Non-Current Liabilities (2025 - 2026)

Updated

Pelthos Therapeutics' Other Non-Current Liabilities was $33.34 million in Q2 2026, up 4.3% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Other Non-Current Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Pelthos Therapeutics came in at $30.05 million.

  • Per Business Quant data, PTHS's Other Non-Current Liabilities in the three quarters before Q2 2026 was $31.96 million (Q1 2026), $30.05 million (Q4 2025) and $26.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pelthos Therapeutics 79.95 Mn -8.44 Mn 11.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.34 Mn
Mar 31, 2026 31.96 Mn
Dec 31, 2025 30.05 Mn
Sep 30, 2025 26.18 Mn
API Access

Pelthos Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PTHS&period=max&api_key=YOUR_API_KEY